• About Us/
  • News/
  • Investor Area/
  • Contact/
  • Home/

  • Life Sciences
  • Technology

  • Overview
  • Team
  • Companies
  • News & Events

  • Advent Venture Partners
  • Life Sciences


  • Private Companies
  • Publicly Listed
  • Exited Investments
  • Exit History

  • 4-Antibody

    Novel antibody technology

  • Acutus
    Medical

    Cardiac mapping system

  • Algeta

    Alpha emitter anticancer agents.

  • Avila

    Cancer, autoimmune and
    viral infection small drugs

  • Biocartis

    Novel molecular diagnostics platform

  • CardiacAssist

    Extracorporeal ventricular assist device

  • CardiAQ
    Valve
    Technologies

    Transcatheter Mitral Valve
    Implantation system

  • CardioKine

    Cardio-renal drug

  • Cellnovo

    Medical Devices

  • CN
    Creative

    Innovative solutions focused on smoking cessation and harm reduction

  • CoCo
    Therapeutics

    Treatment for Alzheimer's disease

  • Conatus
    Pharmaceuticals

    Therapeutics for liver disease

  • Emergent
    Biosolutions

    Developing vaccines and therapeutics

  • EUSA
    Pharma

    Trans-Atlantic speciality
    pharmaceutical company

  • F2G

    Anti-fungal therapeutics

  • Helical
    Solutions

    Treatment for Atrial Fibrillation

  • Infinity
    Pharmaceuticals

    Chemical genomic
    based drug discovery

  • MediGene

    Anti-cancer drugs

  • Micromet

    Antibody-based cancer, inflammation and autoimmune disease drugs

  • NeRRe
    Therapeutics

    Novel neurokinin antagonists

  • Oxagen

    Asthma treatment

  • Pathwork
    Diagnostics

    Cancer Molecular diagnostics

  • PowderMed

    Medical Devices

  • RespiVert

    Respiratory drug discovery and development.

  • Santarus

    Gastrointestinal disease drug

  • Speciality
    European
    Pharma

    Specialty Pharmaceuticals

  • Targacept

    Targeting neuronal nicotinic acid receptors

  • Thiakis

    Obesity therapy

  • UniQure

    Gene therapy for orphan indications

  • Versartis

    Endocrine disorders
    therapeutic proteins


  • Follow Advent
  • Tech Blog
  • Twitter
  • LinkedIn

  • Legal and Regulatory Matters

©2013 Advent Venture Partners